Rxwire
In the news · 48h FDA 38 Eli Lilly 17 Roche 9 Merck & Co. (MSD) 7 Johnson & Johnson 4 AstraZeneca 3 AbbVie 2 Daiichi Sankyo 2
Approvals & regulatory · first seen yesterday, updated 11h ago

AstraZeneca granted EU label expansion for COPD therapy, Trixeo in asthma

2 outlets AstraZeneca

The single-inhaler triple therapy becomes the first treatment of its kind approved in the EU for asthma patients aged 12 and older, expanding its existing COPD indication

Summary from Manufacturing Chemist.

Coverage 2 articles · 2 outlets

  1. Seeking Alpha Healthcare
    AstraZeneca granted EU label expansion for COPD therapy, Trixeo in asthma
  2. Manufacturing Chemist
    AstraZeneca’s Trixeo approved in EU for asthma